Market Closed - Nyse 04:00:01 2024-05-28 pm EDT 5-day change 1st Jan Change
223.4 USD -2.52% Intraday chart for STERIS plc -3.13% +1.61%
Sales 2024 5.5B Sales 2025 * 5.53B Capitalization 22.65B
Net income 2024 378M Net income 2025 * 659M EV / Sales 2024 4.04 x
Net Debt 2024 * 2.94B Net Debt 2025 * 2.46B EV / Sales 2025 * 4.54 x
P/E ratio 2024
59 x
P/E ratio 2025 *
32.8 x
Employees 17,000
Yield 2024 *
0.91%
Yield 2025 *
1%
Free-Float 99.73%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.52%
1 week-4.02%
Current month+9.21%
1 month+9.56%
3 months-3.93%
6 months+10.92%
Current year+1.61%
More quotes
1 week
223.30
Extreme 223.3
231.55
1 month
202.70
Extreme 202.7
239.19
Current year
197.82
Extreme 197.82
239.19
1 year
195.47
Extreme 195.47
254.00
3 years
159.21
Extreme 159.21
255.93
5 years
105.69
Extreme 105.69
255.93
10 years
49.78
Extreme 49.78
255.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 18-07-31
Director of Finance/CFO 56 14-01-31
Investor Relations Contact - 04-04-30
Members of the board TitleAgeSince
Director/Board Member 74 08-03-31
Director/Board Member 74 03-09-30
Director/Board Member 58 20-07-27
More insiders
Date Price Change Volume
24-05-28 223.4 -2.52% 457,429
24-05-24 229.2 +1.04% 510,545
24-05-23 226.8 -1.64% 635,803
24-05-22 230.6 0.00% 484,889
24-05-21 230.6 -0.92% 657,302

Delayed Quote Nyse, May 28, 2024 at 04:00 pm EDT

More quotes
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%). Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
223.4 USD
Average target price
243.5 USD
Spread / Average Target
+9.00%
Consensus